Researchers at MIT, NYU, and UCLA develop an approach to help evaluate whether large language models like GPT-4 are equitable enough to be clinically viable for mental health support.
In a recent commentary, a team from MIT, Equality AI, and Boston University highlights the gaps in regulation for AI models and non-AI algorithms in health care.
Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.
MIT and Sierra Leone’s Ministry of Health launch specialized program to train future clinicians on the fabrication of artificial limbs and braces for people with disabilities.
Physician and engineer Giovanni Traverso found an early passion for molecular genetics, leading to an interdisciplinary career helping others.
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
Marzyeh Ghassemi works to ensure health-care models are trained to be robust and fair.
Thomas Heldt, associate director of IMES, describes how he collaborates closely with MIT colleagues and others at Boston-area hospitals.
“MouthIO” is an in-mouth device that users can digitally design and 3D print with integrated sensors and actuators to capture health data and interact with a computer or phone.
SMART researchers find mesenchymal stromal cells are an attractive alternative to current costly, time-intensive treatments.
Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
Hanna Adeyema and Carolina Haass-Koffler discuss the substance use disorder crisis and the future of innovation in the field.
A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.
While women and men self-reported similar vaccination rates, unvaccinated women had less intention to get vaccinated than men.
A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.